Brief: Abbvie Inc. Reports 9.0 % Passive Stake In Xilio Therapeutics, Inc. As Of Feb 11 - SEC Filing
18/02/2025 22:39
Feb 18 (Reuters) - Xilio Therapeutics Inc XLO.O :
* ABBVIE INC. REPORTS 9.0 % PASSIVE STAKE IN XILIO
THERAPEUTICS,
INC. AS OF FEB 11 - SEC FILING
Source text: ID:n0001104659-25-014772
Further company coverage: XLO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Xilio Therapeutics
See all newsXilio Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Xilio Therapeutics Inc expected to post a loss of 92 cents a share - Earnings Preview
Brief: Xilio Therapeutics Reports Second Quarter 2026 Financial Results And Provides Pipeline And Business Updates
U.S. STOCKS ON THE MOVE-Palantir, AeroVironment, Valvoline
U.S. STOCKS ON THE MOVE-Medtronic, AeroVironment, Tesla